Literature DB >> 9589249

Do postmenopausal women with NIDDM have a reduced capacity to deposit and conserve lower-body fat?

R M Stoney1, K Z Walker, J D Best, P D Ireland, G G Giles, K O'Dea.   

Abstract

OBJECTIVE: To compare regional body fat distribution and sex hormone status of postmenopausal women with NIDDM with those of age- and BMI-matched normoglycemic women. RESEARCH DESIGN AND METHODS: The regional body fat distribution and sex hormone status of 42 postmenopausal women with NIDDM were compared with those of 42 normoglycemic women matched for age and BMI, who served as control subjects. Body composition was measured by dual-energy X-ray absorptiometry, and sex hormone-binding globulin (SHBG) and testosterone were measured in serum.
RESULTS: Although the levels of total body fat were similar between the two groups, the women with NIDDM had significantly less lower-body fat (LBF) (P < 0.01) than the control subjects matched for age and BMI. This pattern of fat deposition in women with NIDDM was accompanied by an androgenic hormone profile, with decreased SHBG concentration and an increased free androgen index (P < 0.05 and P < 0.01, respectively).
CONCLUSIONS: A reduced capacity to deposit and/or conserve LBF may be an independent factor associated with (or may be a marker of) the metabolic manifestations of the insulin resistance syndrome in women with NIDDM. The possibility that the smaller relative accumulation of LBF is a consequence of the androgenic hormonal profile should be investigated in future studies.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9589249     DOI: 10.2337/diacare.21.5.828

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  7 in total

1.  Endogenous hormones and coronary heart disease in postmenopausal women.

Authors:  Yu Chen; Anne Zeleniuch-Jacquotte; Alan A Arslan; Oktawia Wojcik; Paolo Toniolo; Roy E Shore; Mortimer Levitz; Karen L Koenig
Journal:  Atherosclerosis       Date:  2011-03-01       Impact factor: 5.162

2.  Altered body composition in type 2 diabetes mellitus.

Authors:  S Heshka; A Ruggiero; G A Bray; J Foreyt; S E Kahn; C E Lewis; M Saad; A V Schwartz
Journal:  Int J Obes (Lond)       Date:  2008-01-29       Impact factor: 5.095

3.  Adipose tissue distribution is different in type 2 diabetes.

Authors:  Dympna Gallagher; David E Kelley; Jung-Eun Yim; Natasha Spence; Jeanine Albu; Lawrence Boxt; F Xavier Pi-Sunyer; Stanley Heshka
Journal:  Am J Clin Nutr       Date:  2009-01-21       Impact factor: 7.045

Review 4.  Menopause care for obese and diabetic women.

Authors:  J Verhaeghe
Journal:  Facts Views Vis Obgyn       Date:  2009

5.  The Association between Body Composition using Dual energy X-ray Absorptiometry and Type-2 Diabetes: A Systematic Review and Meta-Analysis of Observational studies.

Authors:  Preeti Gupta; Carla Lanca; Alfred T L Gan; Pauline Soh; Sahil Thakur; Yijin Tao; Neelam Kumari; Ryan E K Man; Eva K Fenwick; Ecosse L Lamoureux
Journal:  Sci Rep       Date:  2019-09-02       Impact factor: 4.379

6.  Altered features of body composition in older adults with type 2 diabetes and prediabetes compared with matched controls.

Authors:  Kirsten E Bell; Michael T Paris; Egor Avrutin; Marina Mourtzakis
Journal:  J Cachexia Sarcopenia Muscle       Date:  2022-02-16       Impact factor: 12.910

7.  Genetic evidence that raised sex hormone binding globulin (SHBG) levels reduce the risk of type 2 diabetes.

Authors:  John R B Perry; Michael N Weedon; Claudia Langenberg; Anne U Jackson; Valeriya Lyssenko; Thomas Sparsø; Gudmar Thorleifsson; Harald Grallert; Luigi Ferrucci; Marcello Maggio; Giuseppe Paolisso; Mark Walker; Colin N A Palmer; Felicity Payne; Elizabeth Young; Christian Herder; Narisu Narisu; Mario A Morken; Lori L Bonnycastle; Katharine R Owen; Beverley Shields; Beatrice Knight; Amanda Bennett; Christopher J Groves; Aimo Ruokonen; Marjo Riitta Jarvelin; Ewan Pearson; Laura Pascoe; Ele Ferrannini; Stefan R Bornstein; Heather M Stringham; Laura J Scott; Johanna Kuusisto; Peter Nilsson; Malin Neptin; Anette P Gjesing; Charlotta Pisinger; Torsten Lauritzen; Annelli Sandbaek; Mike Sampson; Ele Zeggini; Cecilia M Lindgren; Valgerdur Steinthorsdottir; Unnur Thorsteinsdottir; Torben Hansen; Peter Schwarz; Thomas Illig; Markku Laakso; Kari Stefansson; Andrew D Morris; Leif Groop; Oluf Pedersen; Michael Boehnke; Inês Barroso; Nicholas J Wareham; Andrew T Hattersley; Mark I McCarthy; Timothy M Frayling
Journal:  Hum Mol Genet       Date:  2009-11-18       Impact factor: 6.150

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.